Phase II study on prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis by placement of 4Fr prophylactic pancreatic duct stent in patients who is performed endoscopic pancreatic duct injection (multicenter study)
Not Applicable
- Conditions
- biliary duct disease
- Registration Number
- JPRN-UMIN000031972
- Lead Sponsor
- Wakayama Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 250
Inclusion Criteria
Not provided
Exclusion Criteria
.acute pancreatitis .postoperative reconstructed intestinal tract (Billroth ii, Roux-en-Y method) .patient with serious systemic illness, dangerous condition of life .intraductal papillary mucinous neoplasm .complete obstruction of main pancreatic duct .patient who already registered in this study once
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method